Jinlin Niu
6 Papers
9 Citations
Jinlin Niu is an academic researcher. The author has contributed to research in topics: Gene & Cancer. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Characterization of the recombinant porcine pancreas phospholipase A2 expressed in Pichia pastoris GS115 and its application to synthesis of 2-DHA-PS
TL;DR: In this paper, the codon-optimized gene pla 2 m, encoding porcine pancreas phospholipase A 2 (ppPLA 2 ), was expressed in Pichia pastoris GS115 for functional characterization of recombinant PLA 2 M (rPLA 2 M).
9
Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment.
Qi-Sheng Ma,Yi Fan Zhang,Chenglan Li,Weixing Zhang,Lu-Jiang Yuan,Jinlin Niu,Jian-Ying Song,Sai-Yang Zhang,Hong-Min Liu +8 more
TL;DR: In this paper , a series of tranylcypromine-based derivatives were designed and synthesized, and compound 12u exhibited the most potent inhibitory potency on LSD1 (IC50 = 25.3 nM), and also displayed good antiproliferative effects on MGC-803, KYSE450 and HCT-116 cells with IC50 values of 14.3, 22.8 and 16.3 μM, respectively.
5
ALK-based dual inhibitors: Focus on recent development for non-small cell lung cancer therapy
Qiuge Liu,Ji Wu,Zi-Yue Wang,Bing-Bing Chen,Yi-Fei Du,Jinlin Niu,Sai Zhang +6 more
- 01 Apr 2025
1
Advances in light-controllable PROTACs: Design strategies, therapeutic applications and current challenges.
Ji Wu,Zi-Yue Wang,Shi-Xuan Tan,Ting-Yu Li,Bing-Bing Chen,Qi-Qi Chen,Hao Li,Jinlin Niu,Xiang-Jing Fu,Jian Song,Sai Zhang +10 more
- 18 Dec 2025
Hydrazide-based HDAC inhibitors and PROTAC degraders in drug discovery: Recent developments and therapeutic applications
Hao Li,Yu-Xuan Zhao,Jinlin Niu,Jian Song,Sai Zhang +4 more